Authors
Latest:
The Global Vaccine R&D Pipeline and Delivery ImplicationsThe current vaccine pipeline brings promise of significant global health advancements—yet development gaps remain, and the future delivery challenges must be considered.
Latest:
The EU Regulations Catching US Pharma Companies Off GuardCompanies that understand the regulatory environment in Europe can keep their trials on budget and on schedule.
Latest:
Balancing Marketability and Risk in a Drug NameNavigating the challenging landscape of pharmaceutical naming—where a name must meet regulatory approval, clear trademark hurdles, and capture market attention all at once.
Latest:
A Single Source of Truth for KOL MappingCoordination of KOL engagement is all but impossible if the information an organization collects about them is fragmented. What is needed is a centralized database that captures all information about an expert from the multiple touch points across functions and geographies.
Latest:
How Open-Source Benefits Clinical TrialsAs therapeutics become more personalized and targeted, technology, such as open-source software, can help companies innovate.
Latest:
Addressing Health Disparities Through Robust Patient Support ProgramsIdentifying unique traits in patients is key to creating the most effective support programs.
Latest:
Reimbursement Benchmark Share: An Objective Measure of the Impact of Product Reimbursement on Sales PerformanceKnowing that product reimbursement affects performance and varies by geography, this article proposes the use of Reimbursement Benchmark Share (RBS) to quantify the influence of reimbursement on a product’s performance.
Latest:
Unlock Social: 5 Ways to Accelerate Your Social Media SuccessWebinar Date/Time: Tue, Apr 23, 2024 1:00 PM EDT
Latest:
The Amazon Effect: A Data-Fueled Customer ExperienceWhat the future emergence of Amazon Pharmacy and the company’s aim to own the health experience may mean for pharma manufacturers’ engagement strategies and role in Rx delivery.
Latest:
Three Ways to Overcome Any Market ChallengePandemic-reinforced principles of successful drug launch.
Latest:
Patients Are Ready for a Digital Future, Here’s Pharma’s Path Toward the Next Growth HorizonRecent advances from COVID-19 vaccine development put pharma in place to further grow relationship with patients.
Latest:
How a “Push and Pull” Approach Can Maximize Innovation Value through HTAsHow can companies adapt their single evidence package at launch into multiple, tailored versions for HTAs that vary across different countries and regions?
Latest:
A Good Time to ‘Revamp’ Sales and MarketingHow one COVID-sparked model could help usher in needed reset.
Latest:
2022 Prescription TrendsThe market for prescription medicines in the United States was subject to major shifts in use across therapeutic areas in 2022, reflecting changes in patient health needs, the development, and availability of novel medicines, and complex market dynamics.
Latest:
Reducing Prescription Drug Costs for Seniors: The ABCs of ASP for Part DOutlining the steps to a payment approach for Medicare Part D drugs that provides savings for patients.
Latest:
A ‘Sign’ of the Times: Digital Contract TransformationThe pandemic has raised the stakes for companies pursuing new data-harnessing capabilities in contract management and KPI benchmarking and tracking.
Latest:
Key Considerations for Senior Executives Related to Quality CultureExploring practical points to further understand and strengthen quality culture.
Latest:
Best Practices to Ensure Sourcing and Outsourcing Are Strategic Levers for Competitive AdvantageOptimally designed SSO program can allow companies to deliver therapies to patients faster and at a more affordable cost.
Latest:
It’s Time to Invest in Reproductive Medicine and Maternal HealthAmidst lack of funding for women’s health research, industry must collaborate now to advance RMMH.
Latest:
Next-Gen Partnerships: The Ascent of Advanced TherapiesWith added push from the COVID-19 pandemic, investment in promising RNA- and cell and gene therapy-based treatments and technology via industry dealmaking is growing considerably.
Latest:
Leveraging Market Research & User Experience Research in Life SciencesThe right market research insights provide a richer, more-nuanced picture of your customers as people, not just as numbers on a spreadsheet.
Latest:
Medical Affairs: Support Function or Competitive Advantage? How AI & NLP Can Ensure It is BothTreating medical affairs solely as a support function is penny-wise and pound foolish. With the advent of machine learning, the medical affairs team can innovate and perform their many functions better and more efficiently.
Latest:
Building Resiliency: Essential Leadership Principles for 2024Embracing business imperatives such as operational efficiency and a focus on a patient-centric approach can help pharma leaders provide a stable foundation amid lingering uncertainty.
